FDA admonishes Shire for Adderall XR promotion
The FDA Division of Drug Marketing, Advertising, and Communications (DDMAC) issued a warning letter to Shire
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.